We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Amplitude Healthcare Acquisition Corporation | NASDAQ:AMHC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.12 | 14.65 | 15.00 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
JASPER THERAPEUTICS, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
471871 103
(CUSIP Number)
January 27, 2023
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO. 471871 103 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Soleus Capital Master Fund, L.P. CHECK THE APPROPRIATE
BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ SEC USE ONLY CITIZENSHIP OR PLACE OF
ORGANIZATION Cayman
Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER 0 SHARED VOTING POWER 6,250,000 (1) SOLE DISPOSITIVE POWER 0 SHARED DISPOSITIVE POWER 6,250,000
(1) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,250,000 (1) CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.7% (2) TYPE OF REPORTING
PERSON (SEE INSTRUCTIONS) FI FOOTNOTES The shares of common stock reported in this row are held by Soleus Capital Master Fund, L.P. (Master
Fund). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy
Levy is the sole managing member of Soleus Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an
admission that they are the beneficial owners of such securities for purposes of Section 13(d) of the Exchange Act, or for any other purpose, except to the extent of their respective pecuniary interests therein. This percentage is calculated based upon 109,321,864 shares of common stock outstanding of the Issuer as of
January 27, 2023, after giving effect to the issuance of 69,000,000 shares of common stock (including the exercise of the over-allotment option) pursuant to that certain Underwriting Agreement dated January 25, 2023 between the Issuer, on
the one hand, and the representatives of the several underwriters named therein, on the other hand (the Public Offering), as disclosed in the prospectus supplement that was filed by the Issuer with the Securities and Exchange Commission
on January 25, 2023 in connection with the Public Offering (the Prospectus Supplement).
CUSIP NO. 471871 103 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Soleus Capital, LLC CHECK THE APPROPRIATE
BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ SEC USE ONLY CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER 0 SHARED VOTING POWER 6,250,000 (1) SOLE DISPOSITIVE POWER 0 SHARED DISPOSITIVE POWER 6,250,000
(1) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,250,000 (1) CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.7% (2) TYPE OF REPORTING
PERSON (SEE INSTRUCTIONS) OO FOOTNOTES The shares of common stock reported in this row are held by Master Fund. Soleus Capital, LLC is the sole
general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus
Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial
owners of such securities for purposes of Section 13(d) of the Exchange Act, or for any other purpose, except to the extent of their respective pecuniary interests therein. This percentage is calculated based upon 109,321,864 shares of common stock outstanding of the Issuer as of
January 27, 2023, as reported in the Prospectus Supplement.
CUSIP NO. 471871 103 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Soleus Capital Group, LLC CHECK THE APPROPRIATE
BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ SEC USE ONLY CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER 0 SHARED VOTING POWER 6,250,000 (1) SOLE DISPOSITIVE POWER 0 SHARED DISPOSITIVE POWER 6,250,000
(1) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,250,000 (1) CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.7% (2) TYPE OF REPORTING
PERSON (SEE INSTRUCTIONS) OO FOOTNOTES The shares of common stock reported in this row are held by Master Fund. Soleus Capital, LLC is the sole
general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus
Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial
owners of such securities for purposes of Section 13(d) of the Exchange Act, or for any other purpose, except to the extent of their respective pecuniary interests therein. This percentage is calculated based upon 109,321,864 shares of common stock outstanding of the Issuer as of
January 27, 2023, as reported in the Prospectus Supplement.
CUSIP NO. 471871 103 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Guy Levy CHECK THE APPROPRIATE
BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ SEC USE ONLY CITIZENSHIP OR PLACE OF
ORGANIZATION United
States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER 0 SHARED VOTING POWER 6,250,000 (1) SOLE DISPOSITIVE POWER 0 SHARED DISPOSITIVE POWER 6,250,000
(1) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,250,000 (1) CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.7% (2) TYPE OF REPORTING
PERSON (SEE INSTRUCTIONS) IN FOOTNOTES The shares of common stock reported in this row are held by Master Fund. Soleus Capital, LLC is the sole
general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus
Capital Group, LLC. Each of Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial
owners of such securities for purposes of Section 13(d) of the Exchange Act, or for any other purpose, except to the extent of their respective pecuniary interests therein. This percentage is calculated based upon 109,321,864 shares of common stock outstanding of the Issuer as of
January 27, 2023, as reported in the Prospectus Supplement.
Item 1. 2200 Bridge Pkwy Suite #102 Redwood City, CA
94065 Item 2. Soleus Capital Master Fund, L.P. Soleus
Capital, LLC Soleus Capital Group, LLC Guy Levy Soleus Capital Master Fund, L.P. 104 Field
Point Road, 2nd Floor Greenwich, CT 06830 Soleus Capital, LLC 104 Field Point Road, 2nd Floor Greenwich, CT 06830 Soleus Capital Group, LLC 104 Field Point Road, 2nd Floor Greenwich, CT 06830 Guy Levy c/o Soleus Capital Management, L.P 104 Field Point Road, 2nd Floor Greenwich, CT 06830 Soleus Capital Master Fund, L.P. Cayman Islands Soleus Capital, LLC Delaware Soleus Capital Group, LLC Delaware Guy Levy United States Common Stock
471871 103 Reference is made to Items 5 11 on the preceding pages of this Schedule 13G. Master Fund held, as of the close of business on January 27, 2023, and after giving effect to the Public Offering, an aggregate of 6,250,000 shares of
the common stock of the Issuer. As the general partner of Master Fund, Soleus Capital, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole
managing member of Soleus Capital, LLC, Soleus Capital Group, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus
Capital Group, LLC, Mr. Guy Levy may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of the Shares held by Master Fund. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission that Mr. Levy, Soleus Capital, LLC or Soleus
Capital Group, LLC is the beneficial owner of the shares of the common stock of the Issuer referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose, and such beneficial
ownership is expressly disclaimed, except to the extent of their respective pecuniary interests therein. Not applicable.
Not applicable. Not applicable. Not applicable. Not applicable.
SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement
is true, complete and correct. Footnotes: Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
1
2
3
4
5
6
7
8
9
10
11
12
(1)
(2)
1
2
3
4
5
6
7
8
9
10
11
12
(1)
(2)
1
2
3
4
5
6
7
8
9
10
11
12
(1)
(2)
1
2
3
4
5
6
7
8
9
10
11
12
(1)
(2)
(a)
Name of Issuer
Jasper Therapeutics, Inc.
(b)
Address of Issuers Principal Executive Offices
(a)
Name of Person(s) Filing
(b)
Address of Principal Business Office or, if none, Residence
(c)
Citizenship
(d)
Title of Class of Securities
(e)
CUSIP Number
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
☐
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
☐
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
☐
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. ☐78c).
(d)
☐
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
(e)
☐
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)
☐
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)
☐
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
☐
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
☐
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
☐
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
(k)
☐
Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with
§240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Item 4.
Ownership.
Item 5.
Ownership of Five Percent or Less of a Class
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Item 8.
Identification and Classification of Members of the Group
Item 9.
Notice of Dissolution of Group
Item 10.
Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Date: January 30, 2023
Soleus Capital Master Fund, L.P.
By:
Soleus Capital, LLC, its General Partner
By:
Soleus Capital Group, LLC, its Managing Manager
By:
/s/ Guy Levy
Name:
Guy Levy
Title:
Managing Member
Date: January 30, 2023
Soleus Capital, LLC
By:
Soleus Capital Group, LLC, its Managing Manager
By:
/s/ Guy Levy
Name:
Guy Levy
Title:
Managing Member
Date: January 30, 2023
Soleus Capital Group, LLC
By:
/s/ Guy Levy
Name:
Guy Levy
Title:
Managing Member
Date: January 30, 2023
/s/ Guy Levy
Name:
Guy Levy
1 Year Amplitude Healthcare Acq... Chart |
1 Month Amplitude Healthcare Acq... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions